Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Arthur Tzianabos currently holds 118,696 shares of Stoke Therapeutics, Inc. (STOK), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Arthur Tzianabos has been a net seller of STOK stock. They have purchased $21.7K and sold $3.8M worth of shares.
Arthur Tzianabos's most recent insider trade was on Mar 10, 2026, when they sold 3,955 shares at $0.00 per share.
Arthur Tzianabos serves as Executive at Stoke Therapeutics, Inc. (STOK). They have executed 43 insider transactions totaling $3.8M over their tenure at the company.
Arthur Tzianabos holds the position of Executive at Stoke Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 13 years and currently hold a stake valued at $0.
Arthur Tzianabos has shown a selling trading pattern, with $21.7K in total purchases and $3.8M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Arthur Tzianabos was on Feb 19, 2021, when they sold $606.7K worth of STOK shares. This transaction involved 10,000 shares at $60.67 per share.
Arthur Tzianabos currently owns 118,696 shares of Stoke Therapeutics, Inc. (STOK), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Arthur Tzianabos's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Arthur Tzianabos has 43 Form 4 filings on record as an insider at Stoke Therapeutics, Inc..
Set alerts for Arthur Tzianabos and 40,000+ other insiders.